Sutro Biopharma, Inc

SENIOR SCIENTIST, BIOANALYTICS

Sutro Biopharma, Inc$174K — $208K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Ph.D. in PK/ADME, analytical chemistry, or related field with 7+ years of industry experience (12+ years without Ph.D. may be considered)
  • Proven track record in developing and optimizing bioanalytical methods for small molecules and biologics
  • Strong expertise in LC-MS instrumentation, particularly triple quadrupole and high-resolution mass spectrometry
  • Hands-on experience in ADC bioanalysis, including drug-to-antibody ratio (DAR) characterization
  • Demonstrated ability to independently establish new experimental protocols

Responsibilities

  • Lead and implement bioanalytical strategies for discovery, preclinical, and early clinical programs
  • Develop LC-MS/MS-based bioanalytical methods for antibodies, ADCs, and small molecules
  • Transfer bioanalytical methods to CROs and act as the scientific lead
  • Manage CRO relationships for quality data delivery and adhere to timelines
  • Assess drug-to-antibody ratio (DAR) stability using high-resolution mass spectrometry
  • Analyze and communicate DMPK/BA data effectively to teams and collaborators
  • Author DMPK/BA reports for regulatory submissions and publications

Benefits

  • Opportunity to mentor and supervise junior scientists
  • Contribute to the development of organizational processes and infrastructure
  • Work in a collaborative, cross-functional environment
  • Involvement in high-impact projects with potential for significant industry contribution
  • Engagement in innovative work within biologics and antibody-drug conjugates (ADCs)
Full Job Description
SENIOR SCIENTIST, BIOANALYTICS

Position Overview
Sutro Biopharma is seeking a highly motivated and experienced Senior Bioanalytical Scientist to join its Preclinical Development team in South San Francisco, CA. The successful candidate will lead the design and execution of bioanalytical strategies for discovery, preclinical, and early clinical development programs. S/he will be responsible for developing and qualifying bioanalytical methods for small molecules and antibody-drug conjugates (ADCs), including drug-to-antibody ratio (DAR) assessment, and transferring these methods to CROs to enable preclinical and clinical studies. This role requires deep expertise in LC-MS/MS-based bioanalysis and a proven track record of independently driving complex programs in a fast-paced, collaborative environment.
Responsibilities
  • Lead and implement bioanalytical (BA) strategies to address key scientific questions across discovery, preclinical, and early clinical programs
  • Develop stage-appropriate LC-MS/MS-based bioanalytical methods to quantify antibodies, ADCs, and small molecules in various biological matrices
  • Transfer bioanalytical methods to CROs and serve as the primary scientific lead overseeing external studies
  • Manage CRO relationships to ensure high-quality data delivery, adherence to timelines, and alignment with program goals
  • Assess in vitro and in vivo drug-to-antibody ratio (DAR) stability using high-resolution mass spectrometry
  • Analyze, interpret, and clearly communicate DMPK/BA data to internal project teams, senior leadership, and external collaborators
  • Author high-quality DMPK/BA reports to support IND submissions, regulatory filings, patent applications, and publications
  • Mentor and supervise junior bioanalytical scientists as needed
  • Serve as a functional representative on cross-functional project teams, including partnered programs
  • Contribute to the development of organizational processes, infrastructure, and resource planning, including capital equipment and budget considerations
Qualifications:
  • Ph.D. in PK/ADME, analytical chemistry, or a related field with 7+ years of relevant industry experience (biologics and small molecules)
    • Exceptional candidates without a Ph.D. with 12+ years of relevant experience may be considered
  • Proven track record of developing and optimizing quantitative bioanalytical methods for small molecules, biologics, and conjugates
  • Strong expertise in LC-MS instrumentation, including triple quadrupole and high-resolution mass spectrometry
  • Hands-on experience with ADC bioanalysis, including DAR characterization
  • Demonstrated ability to independently establish new experimental protocols using novel methods or techniques
  • Experience with ligand-binding assays is a plus
  • Experience developing automated sample handling and assay workflows is preferred
  • Familiarity with PK analysis and interpretation
  • Working knowledge of regulatory guidance (FDA, ICH) relevant to bioanalytical and DMPK studies
  • Experience with LIMS and common analytical/data processing software
  • Demonstrated ability to author technical reports supporting regulatory filings, patents, and publications
  • Excellent communication skills and ability to thrive in a collaborative, cross-functional environment


Sound exciting? Apply today and join our team!

The anticipated salary range for fully qualified candidates applying for this role at Sutro Biopharma's California based locations will be $174,000 - $208,000 (not including bonus, equity, and benefits). The final salary offered will be dependent on several factors that include and are not limited to relevant previous experience, job responsibilities and duration of experience, the type and length of experience within the industry and education.

About Sutro Biopharma, Inc

Sutro Biopharma is a clinical-stage biotechnology company that develops novel cancer therapies. The company was founded in 2003 and is based in South San Francisco, California. Sutro's proprietary technology platform allows for the rapid design and production of protein therapeutics, which can be used to target specific cancer cells. The company's lead product candidate, STRO-001, is a potential treatment for multiple myeloma and other B-cell malignancies. Sutro has partnerships with several pharmaceutical companies, including Merck and Celgene, to develop and commercialize its products. In 2018, Sutro went public on the NASDAQ stock exchange.
Learn more about Sutro Biopharma, Inc
Size
234 employees
Market Cap
$394.6 million
Industry
Net Income
$12.6 million
Founded
2003
5 Year Trend
+0.7%
Revenue
$45.7 million
NASDAQ

Similar Jobs

More Jobs at Sutro Biopharma, Inc

More Pharmaceuticals & Biotech Jobs

Find similar SENIOR SCIENTIST, BIOANALYTICS jobs: